Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

BioStock Studio: CombiGene's CEO provides an operational update

Lärkberget

In connection with the release of Combigene's year-end report for 2022, the gene therapy company's CEO Jan Nilsson visited BioStock for a video interview. In addition to a review of the company's ongoing projects, not least the recently initiated pain project with Danish Zyneyro, we get to know more about what is on the agenda for Combigene in 2023.

Watch the interview with CombiGene's CEO Jan Nilsson at biostock.se:

https://www.biostock.se/en/2023/02/combigenes-ceo-provides-an-operational-update/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.